Accumulating evidences show that EIF5A2 plays important roles in enhancing anchorage-independent growth, xenograft tumor growth, increasing cancer cell metastasis, and promoting treatment resistance through multiple pathways [15–18]. The gene discussed is EIF5A2; the disease is cancer.